Anti-obesity medications, through their significant impact on weight reduction, present a promising approach to addressing OSA in individuals with obesity
More must-read commentary published by Fortune : Markets have overestimated AI-driven productivity gains, says MIT economist Private equity is devouring the economy as boomer entrepreneurs exitbut a new approach to employee ownership can change that The Godmother of AI says Californias well-intended AI bill will harm the U.S
Phentermine and Vyvanse drug warnings Patients who should not use Vyvanse include those who have preexisting heart conditions like high blood pressure (since it can cause cardiovascular reactions), a medical history of substance abuse, hypersensitivity to amphetamines, or those who have taken an MAOI within 14 days
Cerebrospinal fluid metabolite alterations in patients with different etiologies, diagnoses, and prognoses of disorders of consciousness
This study analyzes the link between these drugs and biliary adverse events (AEs) using the FDA Adverse Event Reporting System (FAERS) to enhance clinical safety